A new meta-analysis has found that SGLT2 inhibitors can reduce the risk of dialysis, transplantation, or death due to kidney disease in people with type 2 diabetes.
from Kidney Disease News -- ScienceDaily https://ift.tt/2Uz8GiS
Friday, 6 September 2019
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment